ArticleBlood advances2024

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

Esperanza Martín-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.